作者
Anand Swaminath,Sameer Parpia,Marcin Wierzbicki,Vijayananda Kundapur,Sergio Faria,Gordon Okawara,Theodoros Tsakiridis,Naseer Ahmed,Alexis Bujold,Khalid Hirmiz,Timothy Owen,Nelson Leong,Kevin Ramchandar,Édith Filion,Harold Lau,Zsolt Gabos,Robert M. Thompson,Brian Yaremko,S. Mehiri,Alexander V. Louie,Kimmen Quan,Mark N. Levine,James R. Wright,Timothy J. Whelan
摘要
Stereotactic body radiotherapy (SBRT) is widely used for stage I medically inoperable non-small cell lung cancer (NSCLC), yet varied results from randomized clinical trials (RCTs) and concerns in treating centrally located tumors persist.